Effects of Rovalpituzumab Tesirine on Ventricular Repolarization in Patients With Small‐Cell Lung Cancer
Small cell lung cancer (SCLC) is a leading cause of cancer death worldwide, with few treatment options. Rovalpituzumab tesirine (Rova‐T) is an antibody‐drug conjugate that targets delta‐like 3 on SCLC cells to deliver a cytotoxic payload directly to tumor cells. In this study, the cardiac safety pro...
Saved in:
Main Authors: | Jonathan W. Goldman (Author), Minal Barve (Author), Jyoti D. Patel (Author), Antoinette Wozniak (Author), Afshin Dowlati (Author), Alexander Starodub (Author), Taofeek K. Owonikoko (Author), William Edenfield (Author), Scott A. Laurie (Author), Daniel Da Costa (Author), Satwant Lally (Author), Martina Koch (Author), Matthew P. Kosloski (Author), David Hoffman (Author), Grace K. Dy (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rovalpituzumab Tesirine: A Novel DLL3-Targeting Antibody-Drug Conjugate
by: Bilal H. Lashari, et al.
Published: (2018) -
Vesiculobullous eruption with loncastuximab tesirine in a patient with relapsed follicular lymphoma
by: Riyad N.H. Seervai, MD, PhD, et al.
Published: (2024) -
Design of two immunotoxins based rovalpituzumab antibody against DLL3 receptor; a promising potential opportunity
by: Mohammad Hossein Ataee, et al.
Published: (2022) -
Neurocardiac Oscillation in Repolarization and Cardiac Arrhythmias
Published: (2020) -
Early repolarization syndrome in modern interpretation
by: T. V. Ashcheulova, et al.
Published: (2019)